Ruxolitinib
Drug timelines are a Plus or Pro feature.
200 regulatory and trial events tracked for Ruxolitinib, covering 2012-01-20 to 2026-07-09. Get the full timeline:
Most recent: Clinical Trial Results: Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis. [Phase 2]